Current screening modalities for prostate cancer rely on serologic testing for PSA and transrectal biopsy; however, many prostate cancers behave indolently.Because aggressively growing tumors depend o
Supplementary Figure S1 to S7 for manuscript (Exploration of a novel prognostic nomogram and diagnostic biomarkers based on the activity variations of hallmark gene sets in hepatocellular carcinoma).